Clinical Trials Browser

Phase 1 × cMET-dysregulated Advanced Solid Tumors × Caffeine × Clear all

NCT02520752 2020-12-10

A DDI Study to Assess the Effect of INC280 on the PK of Midazolam and Caffeine in Patients With cMET-dysregulated Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

cMET-dysregulated Advanced Solid Tumors